PVI
ELGX

Pura Vida Investments’s Endologix Inc ELGX Stock Holding History

Pura Vida Investments’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-460
Closed -$26K – 100
2016
Q4 		$26K Buy
+460
New +$42.1K 0.01% 66

Other funds holding ELGX

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

Pura Vida Investments's ELGX Position: Q1 2017 in Review

Pura Vida Investments sold out of Endologix Inc (ELGX) in Q1 2017, closing a stake of 50,000 shares — an estimated $3.31M sold.

Pura Vida Investments first reported a position in ELGX in Q3 2015 and held it in 5 quarters. The position peaked at $3.65M in Q1 2016. 129 funds tracked by Wall St. Rank hold ELGX as of Q1 2017.

  • Pura Vida Investments reported no remaining Endologix Inc position as of Q1 2017 after selling out during the quarter.
  • Pura Vida Investments sold 50,000 Endologix Inc shares in Q1 2017, an estimated $3.31M.
  • Pura Vida Investments first reported a position in Endologix Inc in Q3 2015 and held it in 5 quarters.
  • Pura Vida Investments's Endologix Inc position peaked at $3.65M in Q1 2016.
  • 129 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2017.

Based on Pura Vida Investments's 13F filing for Q1 2017, filed 15 May 2017.